General Statement of Disclosure:

CONSULTING FEES/HONORARIA: CiVi(MODEST), Regeneron(SIGNIFICANT), Resverlogix(MODEST), Amarin(SIGNIFICANT), NewAmsterdam(SIGNIFICANT), Silence(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Sanofi-Aventis(SIGNIFICANT), Lexicon(SIGNIFICANT), Esperion(MODEST)

View Full Disclosure